Verrica Pharmaceuticals (NASDAQ:VRCA) PT Raised to $14.00 at HC Wainwright

Verrica Pharmaceuticals (NASDAQ:VRCA – Free Report) had its price target increased by HC Wainwright from $13.00 to $14.00 in a report released on Tuesday, Benzinga reports. They currently have a buy rating on the stock. Separately, Needham & Company LLC reiterated a buy rating and issued a $8.00 price objective on shares of Verrica Pharmaceuticals […]

Related Keywords

United States , ,Hedge Funds Weigh In On Verrica Pharmaceuticals ,News Ratings For Verrica Pharmaceuticals Daily ,Avoro Capital Advisors ,Nasdaq ,Capital Management ,Jump Financial ,Verrica Pharmaceuticals ,Kovitz Investment Group Partners ,Verrica Pharmaceuticals Trading Down ,Needham Company ,Verrica Pharmaceuticals Inc ,Free Report ,Pharmaceuticals Trading Down ,Get Free Report ,Investment Group Partners ,Capital Advisors ,Pharmaceuticals Inc ,Verrica Pharmaceuticals Daily ,Nasdaq Vrca ,Vrca ,Medical ,Boost Price Target ,Hc Wainwright ,